Overview
- The World Health Organization said in an Aug. 1 statement that as of July 30 there were 3,605 confirmed Ebola cases and 1,587 deaths in the Democratic Republic of Congo, making this the country's largest recorded outbreak.
- The epidemic is driven by the Bundibugyo strain, for which no licensed vaccine or approved strain-specific treatment exists, so response has relied on testing, isolation, contact tracing, and supportive care.
- International fast-track efforts are under way with early clinical trials of Bundibugyo vaccines and treatments in progress and WHO selecting Singapore-based Hilleman Laboratories on July 30 to develop a leading vaccine candidate.
- Response operations are being undermined by attacks on health facilities, unpaid health-worker strikes, population displacement, and weak contact tracing, with analysts reporting many cases have no known contacts and signaling wide undetected transmission.
- The outbreak has spread beyond Ituri into multiple DRC provinces and produced cases in Uganda and France with patients treated in Germany, raising the risk of further regional seeding and prolonged response needs; past large DRC outbreaks show containment and treatment scale-up can take months.